Controlling tumor progression and recurrence in mice through combined treatment with a PD-L1 inhibitor and a designer Salmonella strain that delivers GM-CSF
Open Access
- 10 July 2024
- journal article
- research article
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 14 (12) , 5479-5492
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Health and Welfare (HR20C0025)
- National Research Foundation of Korea (NRF-RS-2023-00210053)
- National Research Foundation of Korea (NRF-2022R1A2C1009875)
- National Research Foundation of Korea (NRF-2018M3A9H3023081)
- National Research Foundation of Korea (NRF-2022M3E5F1018375)
- National Research Foundation of Korea (NRF-2017R1A5A2015385)
- National Research Foundation of Korea (2019M3E5D5066666)
- National Research Foundation of Korea (- 2020R1A5A2031185)
- Hankuk University of Foreign Studies
- Korea Health Industry Development Institute
This publication has 59 references indexed in Scilit:
- Checkpoint inhibitor/interleukin‐based combination therapy of cancerCancer Medicine, 2022
- Hallmarks of response, resistance, and toxicity to immune checkpoint blockadeCell, 2021
- Cancer therapy in mice using a pure population of CD8+ T cell specific to the AH1 tumor rejection antigenCancer Immunology, Immunotherapy, 2021
- PD-1/PD-L1 inhibitor monotherapy or in combination with chemotherapy as upfront treatment for advanced NSCLC with PD-L1 expression ≥ 50%: Selecting the best strategyCritical Reviews in Oncology/Hematology, 2021
- Cancer immunotherapy: Pros, cons and beyondBiomedicine & Pharmacotherapy, 2020
- Engineering Escherichia coli into a Protein Delivery System for Mammalian CellsACS Synthetic Biology, 2015
- Genetically Programmable Pathogen Sense and DestroyACS Synthetic Biology, 2013
- Immune response induced by Salmonella typhimurium defective in ppGpp synthesisVaccine, 2006
- Salmonella typhimurium specifically chemotax and proliferate in heterogeneous tumor tissue in vitroBiotechnology and Bioengineering, 2006
- A multipartite interaction between Salmonella transcription factor σ28 and its anti-sigma factor FlgM: implications for σ28 holoenzyme destabilization through stepwise bindingJournal of Molecular Biology, 2001